Australia's Integral Diagnostics rises; Macquarie backs co as key pick on strong August volumes

Integral Diagnostics

29/09/2025 01:59

** Shares of Integral Diagnostics IDX.AX advance as much as 1.07% to A$2.840

** Macquarie says Medicare data for August shows strong imaging volumes growth, supporting the medical imaging services provider as its key pick

** Brokerage expects cost synergies, MRI deregulation and a general practitioner bulk billing incentive to drive EPS growth for IDX

** Adds that pathology volumes in August up 7% vs YoY, but were impacted by fee cuts

** Stock has lost 2.9%, YTD

 (Reporting by Kumar Tanishk in Bengaluru)

 ((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk http://www.x.com/thatstanishk;))